Loading…
Chemical Shift and Fat Suppression Magnetic Resonance Imaging of Thymus in Myasthenia Gravis
Myasthenia gravis (MG) is an autoimmune neuromuscular disease leading to fluctuating muscle weakness. Approximately 70% of patients with MG have thymic hyperplasia, and 10-20% of them have thymoma. In MG patients without thymoma, thymectomy should be performed only in selected patients. In contrast,...
Saved in:
Published in: | Canadian journal of neurological sciences 2014-11, Vol.41 (6), p.782-786 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Myasthenia gravis (MG) is an autoimmune neuromuscular disease leading to fluctuating muscle weakness. Approximately 70% of patients with MG have thymic hyperplasia, and 10-20% of them have thymoma. In MG patients without thymoma, thymectomy should be performed only in selected patients. In contrast, thymectomy should be performed in all patients wiih thymoma. In addition, thoracoscopic thymectomy can be used in non-thymomatous MG but not in MG with thymoma, since it has limited exposure. Therefore, it is essential to differentiate thymic hyperplasia from thymoma in MG patients so that physicians can determine the need for thymectomy together with the best approach[1] to use. |
---|---|
ISSN: | 0317-1671 2057-0155 |
DOI: | 10.1017/cjn.2014.104 |